Three Clinical Studies Give GSKâs Cancer Vaccine An Edge
Source: EH News Bureau Author: Staff GlaxoSmithKline Pharmaceuticals Limited (GSK) recently shared the results of three recently published clinical studies, conducted for its cervical cancer vaccineâ"Cervarix. Said Dr Hasit Joshipura, Vice President, South Asia and Managing Director, GSK India, “The findings confirmed that the vaccine offers protection against five of the most common cancer-causing virus types, generates [...]